NCT03170752View on ClinicalTrials.gov

Implementing and Testing a Cardiovascular Assessment Screening Program (CASP)

NACompletedINTERVENTIONAL
Enrollment

169

Participants

Timeline

Start Date

September 28, 2017

Primary Completion Date

September 29, 2018

Study Completion Date

November 14, 2018

Conditions
Cardiovascular Risk FactorSmokingDiabetes MellitusDyslipidemiasHypertensionPhysical ActivityStress, Psychological
Interventions
BEHAVIORAL

Cardiovascular Assessment Screening Program (CASP)

Step 1. Identification of patients; Step 2. Screening utilizing appropriate tools; and Step 3. Actions to follow up on the screening results.

Trial Locations (1)

A1B3V6

Memorial University of Newfoundland, St. John's

All Listed Sponsors
lead

Memorial University of Newfoundland

OTHER

NCT03170752 - Implementing and Testing a Cardiovascular Assessment Screening Program (CASP) | Biotech Hunter | Biotech Hunter